Literature DB >> 28826588

The epidemiology of sepsis in Brazilian intensive care units (the Sepsis PREvalence Assessment Database, SPREAD): an observational study.

Flavia R Machado1, Alexandre Biasi Cavalcanti2, Fernando Augusto Bozza3, Elaine M Ferreira4, Fernanda Sousa Angotti Carrara4, Juliana Lubarino Sousa4, Noemi Caixeta4, Reinaldo Salomao5, Derek C Angus6, Luciano Cesar Pontes Azevedo7.   

Abstract

BACKGROUND: The sepsis burden on acute care services in middle-income countries is a cause for concern. We estimated incidence, prevalence, and mortality of sepsis in adult Brazilian intensive care units (ICUs) and association of ICU organisational factors with outcome.
METHODS: We did a 1-day point prevalence study with follow-up of patients in ICU with sepsis in a nationally representative pseudo-random sample. We produced a sampling frame initially stratified by geographical region. Each stratum was then stratified by hospitals' main source of income (serving general public vs privately insured individuals) and ICU size (ten or fewer beds vs more than ten beds), finally generating 40 strata. In each stratum we selected a random sample of ICUs so as to enrol the total required beds in 1690 Brazilian adult ICUs. We followed up patients until hospital discharge censored at 60 days, estimated incidence from prevalence and length of stay, and generated national estimates. We assessed mortality prognostic factors using random-effects logistic regression models.
FINDINGS: On Feb 27, 2014, 227 (72%) of 317 ICUs that were randomly selected provided data on 2632 patients, of whom 794 had sepsis (30·2 septic patients per 100 ICU beds, 95% CI 28·4-31·9). The ICU sepsis incidence was 36·3 per 1000 patient-days (95% CI 29·8-44·0) and mortality was observed in 439 (55·7%) of 788 patients (95% CI 52·2-59·2). Low availability of resources (odds ratio [OR] 1·67, 95% CI 1·02-2·75, p=0·045) and adequacy of treatment (OR 0·56, 0·37-0·84, p=0·006) were independently associated with mortality. The projected incidence rate is 290 per 100 000 population (95% CI 237·9-351·2) of adult cases of ICU-treated sepsis per year, which yields about 420 000 cases annually, of whom 230 000 die in hospital.
INTERPRETATION: The incidence, prevalence, and mortality of ICU-treated sepsis is high in Brazil. Outcome varies considerably, and is associated with access to adequate resources and treatment. Our results show the burden of sepsis in resource-limited settings, highlighting the need to establish programmes aiming for sepsis prevention, early diagnosis, and adequate treatment. FUNDING: Fundação de Apoio a Pesquisa do Estado de São Paulo (FAPESP).
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28826588     DOI: 10.1016/S1473-3099(17)30322-5

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  75 in total

1.  Sepsis is an important healthcare burden in Latin America: a call to action!

Authors:  Luciano Cesar Pontes Azevedo; Alexandre Biasi Cavalcanti; Thiago Lisboa; Felipe Dal Pizzol; Flavia Ribeiro Machado
Journal:  Rev Bras Ter Intensiva       Date:  2018-12-13

Review 2.  Challenges in the management of septic shock: a narrative review.

Authors:  Daniel De Backer; Maurizio Cecconi; Jeffrey Lipman; Flavia Machado; Sheila Nainan Myatra; Marlies Ostermann; Anders Perner; Jean-Louis Teboul; Jean-Louis Vincent; Keith R Walley
Journal:  Intensive Care Med       Date:  2019-02-11       Impact factor: 17.440

3.  Fluid administration for acute circulatory dysfunction using basic monitoring: narrative review and expert panel recommendations from an ESICM task force.

Authors:  Maurizio Cecconi; Glenn Hernandez; Martin Dunser; Massimo Antonelli; Tim Baker; Jan Bakker; Jacques Duranteau; Sharon Einav; A B Johan Groeneveld; Tim Harris; Sameer Jog; Flavia R Machado; Mervyn Mer; M Ignacio Monge García; Sheila Nainan Myatra; Anders Perner; Jean-Louis Teboul; Jean-Louis Vincent; Daniel De Backer
Journal:  Intensive Care Med       Date:  2018-11-19       Impact factor: 17.440

4.  Should the ART trial change our practice?

Authors:  Alexandre Biasi Cavalcanti; Marcelo Britto Passos Amato; Carlos Roberto Ribeiro de Carvalho
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

5.  Leptospirosis: one of the forgotten diseases.

Authors:  Leandro U Taniguchi; Pedro Póvoa
Journal:  Intensive Care Med       Date:  2019-11-04       Impact factor: 17.440

6.  Neutrophil-lymphocyte ratio in the early diagnosis of sepsis in an intensive care unit: a case-control study.

Authors:  Eduarda Cristina Martins; Lilian da Fe Silveira; Karin Viegas; Andrea Diez Beck; Geferson Fioravantti Júnior; Rafael Viegas Cremonese; Priscila Schmidt Lora
Journal:  Rev Bras Ter Intensiva       Date:  2019-03-21

7.  Characteristics and outcomes of patients with community-acquired and hospital-acquired sepsis.

Authors:  Glauco Adrieno Westphal; Aline Braz Pereira; Silvia Maria Fachin; Ana Carolina Caldara Barreto; Ana Carolina Gern Junqueira Bornschein; Milton Caldeira Filho; Álvaro Koenig
Journal:  Rev Bras Ter Intensiva       Date:  2019 Jan-Mar

Review 8.  Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients With Distributive Shock: A Systematic Review and Meta-analysis.

Authors:  William F McIntyre; Kevin J Um; Waleed Alhazzani; Alexandra P Lengyel; Ludhmila Hajjar; Anthony C Gordon; François Lamontagne; Jeff S Healey; Richard P Whitlock; Emilie P Belley-Côté
Journal:  JAMA       Date:  2018-05-08       Impact factor: 56.272

9.  What Animal Models Can Tell Us About Long-Term Psychiatric Symptoms in Sepsis Survivors: a Systematic Review.

Authors:  Felipe Dal-Pizzol; Gabriela Ferreira de Medeiros; Monique Michels; Aurélien Mazeraud; Fernando Augusto Bozza; Cristiane Ritter; Tarek Sharshar
Journal:  Neurotherapeutics       Date:  2021-01-06       Impact factor: 7.620

10.  Prevalence and outcomes of sepsis in children admitted to public and private hospitals in Latin America: a multicenter observational study.

Authors:  Daniela Carla Souza; Eliane Roseli Barreira; Huei Hsin Shieh; Andrea Maria Cordeiro Ventura; Albert Bousso; Eduardo Juan Troster
Journal:  Rev Bras Ter Intensiva       Date:  2021 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.